Salt-leaching synthesis of porous PLGA nanoparticles

IEEE Transactions on Nanotechnology

Volumn 12, Issue 6, 2013, Pages 1082-1088

  Ilyas, Azhar ^a   Islam, Muhymin ^a   Asghar, Waseem ^a,b,c   Menon, Jyothi U ^a   Wadajkar, Aniket S ^a   Nguyen, Kytai T ^a,d   Iqbal, Samir M ^e,f  

^a University of Texas at Arlington   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e Department of Electrical Engineering   (United States)

^f UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Drug delivery; Drug loading efficiency; Nanoparticles; Nanoporous particles; Porogen; Salt leaching

Indexed keywords

CONTROLLED DRUG DELIVERY SYSTEMS; DRUG-LOADING EFFICIENCY; NANO-POROUS; POLY(LACTIC-CO-GLYCOLIC ACID); POLYMERIC NANOPARTICLES; POROGENS; SALT-LEACHING; THERAPEUTIC APPLICATION;

BIOCHEMISTRY; BIOCOMPATIBILITY; BIODEGRADATION; CONTROLLED DRUG DELIVERY; COPOLYMERS; DRUG DELIVERY; EMULSIFICATION; HYDROMETALLURGY; LEACHING; NANOPARTICLES; PHASE SEPARATION; SCANNING ELECTRON MICROSCOPY;

SYNTHESIS (CHEMICAL);

EID: 84888182612     PISSN: 1536125X     EISSN: None     Source Type: Journal    
DOI: 10.1109/TNANO.2013.2279532     Document Type: Article

References (31)

1. Y. Parajo, I. d'Angelo, A. Horvath, T. Vantus, K. Gyorgy, A. Welle, M. Garcia-Fuentes, and M. J. Alonso, "PLGA: Poloxamer blend microand nanoparticles as controlled release systems for synthetic proangiogenic factors," Eur. J. Pharm. Sci., vol. 41, pp. 644-649, 2010.
2. S. Gelperina, O. Maksimenko, A. Khalansky, L. Vanchugova, E. Shipulo, K. Abbasova, R. Berdiev, S. Wohlfart, N. Chepurnova, and J. Kreuter, "Drug delivery to the brain using surfactant-coated poly (lactide-coglycolide) nanoparticles: Influence of the formulation parameters," Eur. J. Pharm. Biopharm., vol. 74, pp. 157-163, 2009.
3. B. J. Boyd, "Past and future evolution in colloidal drug delivery systems," Expert Opin. Drug Del., vol. 5, pp. 69-85, 2008. (Pubitemid 351234110)
4. S. Bennis, C. Chapey, J. Robert, and P. Couvreur, "Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture," Eur. J. Cancer, vol. 30, pp. 89-93, 1994. (Pubitemid 24058096)
5. W. Asghar, M. Islam, A. S. Wadajkar, Y. Wan, A. Ilyas, K. T. Nguyen, and S. M. Iqbal, "PLGA micro- and nanoparticles loaded into gelatin scaffold for controlled drug release," IEEE Trans. Nanotechnol., vol. 11, no. 3, pp. 546-553, May 2012.
6. B. Magenheim and S. Benita, "Nanoparticle characterization: A comprehensive physicochemical approach," STP Pharm. Sci., vol. 4, pp. 221-241, 1991.
7. R. Jalil and J. R. Nixon, "Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) microcapsules: Problems associated with preparative techniques and release properties," J. Microencapsulation, vol. 7, pp. 297-325, 1990. (Pubitemid 20336774)
8. J. Siepmann, K. Elkharraz, F. Siepmann, and D. Klose, "Howautocatalysis accelerates drug release from PLGA-based microparticles: A quantitative treatment," Biomacromolecules, vol. 6, pp. 2312-2319, 2005. (Pubitemid 41052231)
9. L. Fan and S. K. Singh, Controlled Release: A Quantitative Treatment. Berlin, Germany: Springer, 1989.
10. D. Klose, F. Siepmann, K. Elkharraz, S. Krenzlin, and J. Siepmann, "How porosity and size affect the drug release mechanisms from PLGA-based microparticles," Int. J. Pharm., vol. 314, pp. 198-206, 2006.
11. J. Heeren, T. Grewal, A. Laatsch, D. Rottke, F. Rinninger, R. K. Murray, D. K. Granner, P. A. Mayes, and V. W. Rodwell, "Porous nanoparticles in drug delivery systems," Pak. J. Pharm. Sci., vol. 19, pp. 155-158, 2006.
12. D. L. French, D. A. Edwards, and R. W. Niven, "The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation," J. Aerosol Sci., vol. 27, pp. 769-783, 1996. (Pubitemid 26234318)
13. D. H. Lewis, "Controlled release of bioactive agents from lactide/glycolide polymers," Drugs Pharma. Sci., vol. 45, pp. 1-41, 1990.
14. D. Klose, F. Siepmann, K. Elkharraz, and J. Siepmann, "PLGA-based drug delivery systems: Importance of the type of drug and device geometry," Int. J. Pharm., vol. 354, pp. 95-103, 2008. (Pubitemid 351410450)
15. J. M. Lu, X. Wang, C. Marin-Muller, H. Wang, P. H. Lin, Q. Yao, and C. Chen, "Current advances in research and clinical applications of PLGA-based nanotechnology," Expert Rev. Molecular Diagnostics, vol. 9, pp. 325-341, 2009.
16. K. Pays, J. Giermanska-Kahn, B. Pouligny, J. Bibette, and F. Leal-Calderon, "Double emulsions: How does release occur?" J. Control. Rel., vol. 79, pp. 193-205, 2002. (Pubitemid 34164173)
17. F. Tewes, E. Munnier, B. Antoon, L. Ngaboni Okassa, S. Cohen-Jonathan, H. Marchais, L. Douziech-Eyrolles, M. Souce, P. Dubois, and I. Chourpa, "Comparative study of doxorubicin-loaded poly (lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods," Eur. J. Pharma. Biopharm., vol. 66, pp. 488-492, 2007. (Pubitemid 46756231)
18. F. He, R. X. Zhuo, L. J. Liu, D. B. Jin, J. Feng, and X. L. Wang, "Immobilized lipase on porous silica beads: Preparation and application for enzymatic ring-opening polymerization of cyclic phosphate," Reactive Functional Polymers, vol. 47, pp. 153-158, 2001. (Pubitemid 32264052)
19. G. Zhao, T. Ishizaka, H. Kasai, H. Oikawa, and H. Nakanishi, "Fabrication of unique porous polyimide nanoparticles using a reprecipitation method," Chem. Mater., vol. 19, pp. 1901-1905, 2007. (Pubitemid 46686369)
20. H. J. Chung, H. K. Kim, J. J. Yoon, and T. G. Park, "Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery," Pharma. Res., vol. 23, pp. 1835-1841, 2006. (Pubitemid 44200547)
21. Y. J. Oh, J. Lee, J. Y. Seo, T. Rhim, S. H. Kim, H. J. Yoon, and K. Y. Lee, "Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model," J. Control Rel., vol. 150, pp. 56-62, 2011.
22. S. B. Lee, Y. H. Kim, M. S. Chong, S. H. Hong, and Y. M. Lee, "Study of gelatin-containing artificial skin V: Fabrication of gelatin scaffolds using a salt-leaching method," Biomaterials, vol. 26, pp. 1961-1968, 2005. (Pubitemid 39575338)
23. T. G. Kim, H. J. Chung, and T. G. Park, "Macroporous and nanofibrous hyaluronic acid/collagen hybrid scaffold fabricated by concurrent electrospinning and deposition/leaching of salt particles," Acta Biomaterialia, vol. 4, pp. 1611-1619, 2008.
24. M. Nidhin, R. Indumathy, K. J. Sreeram, and B. U. Nair, "Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates," Bull. Mater. Sci., vol. 31, pp. 93-96, 2008. (Pubitemid 351391019)
25. P. Couvreur, G. Barratt, E. Fattal, P. Legrand, and C. Vauthier, "Nanocapsule technology: A review," Cri. Rev. Therapeutic Drug Carrier Sys., vol. 19, pp. 99-134, 2002.
26. K. Yoshioka, E. Sakai, M. Daimon, and A. Kitahara, "Role of steric hindrance in the performance of superplasticizers for concrete," J. Amer. Ceramic Soc., vol. 80, pp. 2667-2671, 1997. (Pubitemid 127598837)
27. J. F. Chen, H. M. Ding, J. X. Wang, and L. Shao, "Preparation and characterization of porous hollow silica nanoparticles for drug delivery application," Biomaterials, vol. 25, pp. 723-727, 2004. (Pubitemid 37357286)
28. M. S. Arayne and N. Sultana, "Porous nanoparticles in drug delivery systems," Pak. J. Pharma. Sci., vol. 19, pp. 158-169, 2006.
29. C. Y. Sun, C. Qin, C. G. Wang, Z. M. Su, S. Wang, X. L. Wang, G. S. Yang, K. Z. Shao, Y. Q. Lan, and E. B. Wang, "Chiral nanoporous metal-organic frameworkswith high porosity as materials for drug delivery," Adv. Mater., vol. 23, pp. 5629-5632, 2011.
30. J. Cheng, B. A. Teply, I. Sherifi, J. Sung, G. Luther, F. X. Gu, E. Levy-Nissenbaum, A. F. Radovic-Moreno, R. Langer, and O. C. Farokhzad, "Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery," Biomaterials, vol. 28, pp. 869-876, 2007. (Pubitemid 44667020)
31. S. Dhar, F. X. Gu, R. Langer, O. C. Farokhzad, and S. J. Lippard, "Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt (IV) prodrug-PLGA-PEG nanoparticles," Proc. Nat. Acad. Sci., vol. 105, pp. 17356-17361, 2008.